Table 3 Characteristics of participants with and without oesophagitis
CharacteristicAbsence of oesophagitis (n = 911)Presence of oesophagitis (n = 122)RR* (95% CI)
n (%)n (%)
Age (years)
32–44160 (17.6)15 (12.3)1.0
45–54246 (27.0)33 (27.0)1.2 (0.6 to 2.1)
55–64182 (20.0)32 (26.2)1.3 (0.7 to 2.4)
⩾65323 (35.5)42 (34.4)1.1 (0.6 to 2.0)
Sex
Male451 (49.5)77 (63.1)1.7 (1.1 to 2.7)
Female460 (50.5)45 (36.9)1.0
Body mass index (kg/m2)†
<20.030 (3.3)3 (2.5)1.2 (0.4 to 3.9)
20.0–24.9355 (39.0)38 (31.1)1.0
25.0–29.9351 (38.5)54 (44.3)1.2 (0.8 to 1.8)
⩾30.0166 (18.2)26 (21.3)1.0 (0.6 to 1.8)
Smoker
Never485 (53.2)60 (49.2)1.0
Former251 (27.6)35 (28.7)1.0 (0.6 to 1.6)
Current175 (19.2)27 (22.1)1.2 (0.7 to 1.9)
Alcohol consumption
None/occasional340 (37.3)47 (38.5)1.0
Weekly154 (16.9)13 (10.7)0.6 (0.3 to 1.2)
Daily417 (45.8)62 (50.8)0.9 (0.6 to 1.4)
Other factors
Coffee consumption‡724 (79.5)93 (76.2)0.8 (0.5 to 1.3)
Medication use‡§76 (8.3)11 (9.0)1.1 (0.6 to 2.0)
Patient-reported history of
peptic ulcer disease‡148 (16.2)24 (19.7)1.0 (0.6 to 1.5)
Helicobacter pylori infection‡527 (57.8)69 (56.6)1.0 (0.7 to 1.4)
Hiatus hernia‡353 (38.7)91 (74.6)3.3 (2.2 to 5.0)
Reflux symptom frequency
None535 (58.7)40 (32.8)1.0
Less than twice a week183 (20.1)30 (24.6)1.9 (1.2 to 3.0)
At least twice a week193 (21.2)52 (42.6)2.6 (1.7 to 3.9)
  • *RRs were adjusted for all variables in the table.

  • †Body mass index was unknown in nine individuals with no oesophagitis and one individual with oesophagitis.

  • ‡RRs and 95% CIs were calculated with the absence of the studied factor as the reference category in each case.

  • §Defined as the use of aspirin (n = 47), non-steroidal anti-inflammatory drugs (n = 32) or corticosteroids (n = 8).

  • CI, confidence interval; RR, relative risk.